Applied Biosystems and Eppendorf announce Real-Time PCR Instrument Licensing Agreement
"We are pleased to announce our agreement with Applied Biosystems," said Klaus Fink, CEO and President of Eppendorf AG. "We are committed to providing our customers with access to technologies that are of greatest importance for the life sciences sector. Our new product generation of real-time cyclers ensures best practices in laboratories in terms of productivity, simplicity, and ease of use."
The license to Eppendorf is based on U.S. Patent No. 6,814,934 and foreign equivalents. The U.S. Patent & Trademark Office (USPTO) granted Applera this fundamental patent pertaining to real-time PCR instrumentation in November 2004.
Counterpart patents in Europe and Japan have been provisionally held invalid by the corresponding patent offices. Applera has appealed those decisions.
Organizations
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.